Provided by Tiger Fintech (Singapore) Pte. Ltd.

Avis Budget

191.45
-1.1300-0.59%
Volume:307.86K
Turnover:59.73M
Market Cap:6.74B
PE:-3.06
High:197.99
Open:194.86
Low:190.55
Close:192.58
Loading ...

BRIEF-Avis Budget Q1 Adjusted EBITDA USD -93 Million Vs. IBES Estimate USD -125.1 Million

Reuters
·
08 May

Avis Budget Group Reports First Quarter Results

THOMSON REUTERS
·
08 May

Avis Budget Group Inc. Extends and Amends Financing Facilities for U.S. Car Rental Fleet

Reuters
·
07 May

Estimating The Fair Value Of CAR Group Limited (ASX:CAR)

Simply Wall St.
·
05 May

Carclo plc Announces Change in Voting Rights Structure

TIPRANKS
·
02 May

Lyell Immunopharma Announces Oral Presentation of New Clinical Data from the Phase 1/2 Trial of LYL314 for the Treatment of Large B-cell Lymphoma at the International Conference on Malignant Lymphoma (ICML) 2025

GlobeNewswire
·
01 May

Earnings Preview: Avis Budget Group (CAR) Q1 Earnings Expected to Decline

Zacks
·
30 Apr

Carclo plc Reports Strong Financial Performance and Strategic Advancements

TIPRANKS
·
30 Apr

ScaleReady Announces March Biosciences as Recipient of G-Rex® Grant to Advance Manufacturing of Novel CAR-T Cell Therapy

PR Newswire
·
29 Apr

Pfizer Reports Solid First-Quarter 2025 Results And Reaffirms 2025 Guidance

Business Wire
·
29 Apr

Carclo plc Announces Change in Voting Rights

TIPRANKS
·
29 Apr

Senti Bio’s SENTI-202, a First-in-Class Off-the-Shelf Logic Gated Selective CD33 OR FLT3 NOT EMCN CAR NK Cell Therapy, Demonstrates Positive Preliminary Clinical Results in the Treatment of Patients with Relapsed/Refractory AML

GlobeNewswire
·
28 Apr

Avis Budget Group, Inc. (CAR): One of the Best Ride Sharing Stocks to Buy

Insider Monkey
·
28 Apr

3 Volatile Stocks in Hot Water

StockStory
·
28 Apr

5 Broker-Loved Stocks to Keep a Tab on Amid Signs of Easing Trade Woes

Zacks
·
24 Apr

J.P. Morgan Remains a Buy on Avis Budget (CAR)

TIPRANKS
·
24 Apr

Autolus Therapeutics Highlights Advancing Autoimmune Pipeline at R&D Investor Event

GlobeNewswire
·
24 Apr

Immix Biopharma’s NXC-201 NEXICART-2 Clinical Trial Data Selected for Oral Presentation at ASCO 2025

GlobeNewswire
·
23 Apr

Chimeric Therapeutics Advances CAR-T Trials with New Collaborations and Funding

TIPRANKS
·
23 Apr

BioNTech to Report First Quarter 2025 Financial Results and Corporate Update on May 5, 2025

GlobeNewswire
·
22 Apr